Click to Translate to English Click to Translate to French  Click to Translate to Spanish  Click to Translate to German  Click to Translate to Italian  Click to Translate to Japanese  Click to Translate to Chinese Simplified  Click to Translate to Korean  Click to Translate to Arabic  Click to Translate to Russian  Click to Translate to Portuguese


Forum Home Forum Home > Pandemic Preparedness > Medical Intervention & Prevention
  New Posts New Posts RSS Feed - New Drug Tests (With Tamiflu)
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Online Discussion: Tracking new emerging diseases and the next pandemic

New Drug Tests (With Tamiflu)

 Post Reply Post Reply
Author
Message Reverse Sort Order
Mahshadin View Drop Down
Admin Group
Admin Group
Avatar

Joined: January 26 2006
Location: United States
Status: Offline
Points: 3872
Post Options Post Options   Thanks (0) Thanks(0)   Quote Mahshadin Quote  Post ReplyReply Direct Link To This Post Topic: New Drug Tests (With Tamiflu)
    Posted: February 16 2006 at 6:53am

3 New Studies Show Hemispherx Biopharma's Ampligen(R) And Alferon(R) LDO May Provide Defense Against Avian Flu

 

Hemispherx Biopharma, Inc. (AMEX: HEB): Tests Indicate Potential of Ampligen(R) As Vaccine Adjuvant, Boosts Existing Drugs Tamiflu(R), Relenza(R) Up To 100 Times; Alferon(R) LDO Found to Stimulate Production of Interferon, Offering Natural Defense Against Virus

Consortium of Researchers to Present Findings at Today's ASM Biodefense Research Meeting in Washington, D.C.

Hemispherx Biopharma, Inc. (AMEX: HEB), a leader in the clinical development and production of new drug entities for the treatment of viral and immune-based chronic disorders, today unveiled the results of laboratory testing that shows its two investigational immunotherapeutics, Ampligen(R) and Alferon(R), are potentially useful against the H5N1, or avian flu, virus. The pre-clinical research indicates that Ampligen(R), a specifically configured double-stranded RNA, can provide cross-protection against avian flu viral mutations as well as boost the effectiveness of Tamiflu and Relenza, the only two drugs formally recognized for combating bird flu, up to 100 times. Other lab tests, in healthy human volunteers, indicate that Alferon(R) LDO (Low-Dose Oral), a new delivery form of an anti-viral with prior regulatory approval for a category of sexually transmitted diseases, can stimulate genes that induce the production of interferon and other immune compounds, key building blocks in the body's defense system. Hemispherx Biopharma and collaborating government scientists are presenting detailed findings at today's American Society for Microbiology Biodefense Research Meeting in Washington, DC.

Read Full Article Here (Interesting)

 

"In a time of universal deceit, telling the truth is a revolutionary act."   G Orwell
Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down